“Protected time” for clinical investigators in medical oncology: The persistent gap between expectation and reality

By afschroeder • June 25, 2026

Sedrak MS, Ramalingam SS, Sparano JA. "Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality. Cancer. 2026 Jul 1;132(13):e70499. doi: 10.1002/cncr.70499. PMID: 42340000; PMCID: PMC13292070.

Tags: academic oncology, clinical investigator, Hematology/Oncology, Professional development, protected time, Publications

Case Report: A case of HIV seroconversion in a high-risk individual after 35 years of resistance with a CCR5DELTA32 heterozygous genotype

Aziz N, Kim EY, Jamieson BD, Mimiaga MJ, Martinez J, Detels R. Case Report: A case of HIV seroconversion in a high-risk individual after 35[...]

Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer

Tsvetkova O, Gil TE, Kassir G, Castanon S, Kollapaneni SS, Han A, Park SJ, Li R, Velez MA, Lisberg AE. Evaluating datopotamab deruxtecan (Dato-DXd) as[...]

Endometrial Serous Carcinoma Arising From Adenomyosis

Arzoo KK, Berkowitz MJ. Endometrial Serous Carcinoma Arising From Adenomyosis. Cureus. 2026 May 22;18(5):e109441. doi: 10.7759/cureus.109441. PMID: 42333330; PMCID: PMC13283456.